NCT06164769

Brief Summary

Pancreatic enucleation could preserve more healthy pancreatic tissues and functions with a low recurrence risk. However, conventional enucleation can cause significant intraoperative bleeding, especially in which tumors in the pancreatic head, neck, and uncinate process of pancreas, as these tissues are rich in blood supply, mainly including the abdominal trunk and the superior mesenteric artery. In this study, we developed a novel method to control the pancreatic blood flow in laparoscopic enucleation--blocking the abdominal trunk and superior mesenteric artery with vascular occlusion clips in the process of resection, and evaluated its effectiveness and safety.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Mar 2023Jun 2026

Study Start

First participant enrolled

March 1, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

June 2, 2025

Status Verified

May 1, 2025

Enrollment Period

3.2 years

First QC Date

December 1, 2023

Last Update Submit

May 27, 2025

Conditions

Keywords

Enucleationpancreatic tumorsblood lossthe abdominal trunksuperior mesenteric artery

Outcome Measures

Primary Outcomes (1)

  • blood loss

    blockade of both the abdominal trunk and superior mesenteric artery changes the blood loss

    in the procedure

Study Arms (1)

blockade of arteries in laparoscopic pancreatic enucleation

EXPERIMENTAL

In the pancreatic enucleation, Kocher Maneuver was routinely performed at first. Then free the left side of the abdominal trunk and superior mesenteric artery, loose tissues easy to free.After Kocher Maneuver and other surgical procedures, the abdominal trunk and superior mesenteric artery exposed. Before resection of pancreatic tumors, a vascular occlusion clamp clip was used to block the root of both the abdominal trunk and superior mesenteric artery to control the pancreatic blood flow.

Procedure: blocking both the abdominal trunk and superior mesenteric artery in the pancreatic enucleation

Interventions

In the pancreatic enucleation, Kocher Maneuver was routinely performed at first. Then free the left side of the abdominal trunk and superior mesenteric artery, loose tissues easy to free.After Kocher Maneuver and other surgical procedures, the abdominal trunk and superior mesenteric artery exposed. Before resection of pancreatic tumors, a vascular occlusion clamp clip was used to block the root of both the abdominal trunk and superior mesenteric artery to control the pancreatic blood flow.

blockade of arteries in laparoscopic pancreatic enucleation

Eligibility Criteria

Age14 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Benign or borderline tumors diagnosed pathologically, such as pancreatic neuroendocrine tumors, solid pseudopapillary tumors, and cystadenomas, without vascular invasion or distant metastasis
  • Tumors sited in the pancreatic head, neck, and uncinate process of pancreas
  • Blockade of both the abdominal trunk and superior mesenteric artery in the laparoscopic enucleation

You may not qualify if:

  • Highly malignant pancreatic tumors, or tumors with infiltration or metastasis
  • Tumors of the body and tail of the pancreas
  • Transfer to LPD or laparotomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Second Affiliated Hospital of Zhejiang University

Hangzhou, Zhejiang, 310000, China

RECRUITING

Related Publications (1)

  • Song KB, Kim SC, Hwang DW, Lee JH, Lee DJ, Lee JW, Jun ES, Sin SH, Kim HE, Park KM, Lee YJ. Enucleation for benign or low-grade malignant lesions of the pancreas: Single-center experience with 65 consecutive patients. Surgery. 2015 Nov;158(5):1203-10. doi: 10.1016/j.surg.2014.10.008. Epub 2014 Nov 3.

    PMID: 25633730BACKGROUND

Related Links

MeSH Terms

Conditions

Pancreatic NeoplasmsBlood Loss, SurgicalHemorrhage

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsIntraoperative Complications

Study Officials

  • Bo Zhou, Dr.

    The Second Affiliated Hospital, Zhejiang Chinese Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sheng Yan, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Head of Hepatology and Pancreatology, Principal Investigator, Clinical Professor.

Study Record Dates

First Submitted

December 1, 2023

First Posted

December 11, 2023

Study Start

March 1, 2023

Primary Completion (Estimated)

May 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

June 2, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The IPD in the current study are available from central contact person upon reasonable request.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
The data will become available in June 2026 and for 6 months.
Access Criteria
The IPD in the current study are available from central contact person upon reasonable request.

Locations